PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

To evaluate whether the epidermal growth factor receptor (EGFR), K-Ras and PTEN, all members of the EGFR signalling pathway, may affect the clinical response in cetuximab-treated metastatic colorectal cancer (mCRC) patients. Twenty-seven cetuximab-treated mCRC patients were evaluated for drug respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Frattini, M, Saletti, P, Romagnani, E, Martin, V, Molinari, F, Ghisletta, M, Camponovo, A, Etienne, L L, Cavalli, F, Mazzucchelli, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360431/
https://www.ncbi.nlm.nih.gov/pubmed/17940504
http://dx.doi.org/10.1038/sj.bjc.6604009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360431/
https://www.ncbi.nlm.nih.gov/pubmed/17940504
http://dx.doi.org/10.1038/sj.bjc.6604009

Ejemplares similares